Clinical Trials

NCT06051695 | RECRUITING | PHASE1/PHASE2
474 participants

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-04-03
Completion:
2028-06-30
Conditions
  • Rectal Cancer
  • Cancer
  • Solid Tumor, Adult
  • Colorectal Cancer
  • NSCLC
  • Non Small Cell Lung Cancer
  • NSCLC, Recurrent
  • Non-Small Cell Squamous Lung Cancer
  • Pancreas Cancer
  • Pancreatic Neoplasm
  • Colorectal Adenocarcinoma
  • CRC
  • Colon Cancer
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Mesothelioma
  • Mesothelioma, Malignant
  • Ovary Cancer
  • Lung Cancer
  • MESOM
Interventions
  • BIOLOGICAL
  • DIAGNOSTIC_TEST
No Results Yet
NCT06001918 | RECRUITING | PHASE2/PHASE3
400 participants

Nectero EAST System Clinical Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-10-25
Completion:
2028-06-30
Conditions
  • Abdominal Aortic Aneurysm
Interventions
  • DRUG
No Results Yet
NCT05773274 | RECRUITING | PHASE2
100 participants

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-01-12
Completion:
2029-04-30
Conditions
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Digestive System Neuroendocrine Tumor G2
  • Unresectable Digestive System Neuroendocrine Tumor G1
  • Unresectable Digestive System Neuroendocrine Tumor G2
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page